Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Consolidated Statements of Operations [Abstract]        
Revenues $ 1,980,849 $ 1,140,768 $ 5,646,792 $ 3,487,824
Cost of goods sold 542,235 1,130,332 1,483,310 1,893,412
Gross profit 1,438,614 10,436 4,163,482 1,594,412
Costs and expenses:        
Sales and marketing 1,697,317 1,106,942 4,907,800 2,911,944
Research and development 390,395 229,709 1,053,889 436,417
General and administrative 1,393,890 1,300,219 3,772,659 3,225,654
Total costs and expenses 3,481,602 2,636,870 9,734,348 6,574,015
Loss from operations (2,042,988) (2,626,434) (5,570,866) (4,979,603)
Other income (expense):        
Interest expense (145,426) (318,110) (395,769) (954,360)
Interest expense - deferred financing costs (60,013) (169,007) (154,947) (1,200,413)
Change in fair value of warrant liability       62,305
Other income (expense) 11,618 381 9,295 (10,163)
Total other (expense) (193,821) (486,736) (541,421) (2,102,631)
Loss before income taxes (2,236,809) (3,113,170) (6,112,287) (7,082,234)
Income tax benefit     736,434  
Net loss (2,236,809) (3,113,170) (5,375,853) (7,082,234)
Preferred stock dividends (assumes all paid)   329,832   1,028,351
Net loss available to common shareholders $ (2,236,809) $ (3,443,002) $ (5,375,853) $ (8,110,585)
Weighted Average Common Shares outstanding - basic and diluted 11,104,353 1,324,967 11,083,740 1,248,798
Loss Per Common share - basic and diluted $ (0.20) $ (2.60) $ (0.49) $ (6.49)